NovoCure Limited (NVCR)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$12.16
-2.56%
Mkt Cap $1.43B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $174.40M | $174.35M | -0.03% | -$0.41 | -$0.22 | +46.34% | — | — |
| Q4 2025 Oct 30, 2025 | $174.40M | $167.20M | -4.13% | -$0.42 | -$0.33 | +21.43% | — | — |
| Q3 2025 Jul 24, 2025 | $158.81M | $158.81M | -0.00% | -$0.39 | -$0.36 | +7.69% | — | — |
| Q2 2025 Apr 24, 2025 | $153.87M | $154.99M | +0.73% | -$0.47 | -$0.31 | +34.04% | — | — |
| Q1 2025 Feb 27, 2025 | $147.57M | $161.27M | +9.28% | -$0.34 | -$0.61 | -79.41% | — | — |
| Q4 2024 Oct 30, 2024 | $153.05M | $155.09M | +1.34% | -$0.34 | -$0.28 | +17.65% | — | — |
| Q3 2024 Jul 25, 2024 | $143.85M | $150.36M | +4.52% | -$0.40 | -$0.31 | +22.50% | — | — |
| Q2 2024 May 2, 2024 | $135.82M | $138.50M | +1.98% | -$0.43 | -$0.36 | +16.28% | — | — |
| Q1 2024 Feb 22, 2024 | $131.75M | $133.78M | +1.54% | -$0.53 | -$0.45 | +15.09% | — | — |
| Q4 2023 Oct 26, 2023 | $129.30M | $127.32M | -1.53% | -$0.52 | -$0.46 | +11.54% | — | — |
| Q3 2023 Jul 27, 2023 | $124.26M | $126.05M | +1.44% | -$0.50 | -$0.54 | -8.00% | — | — |
| Q2 2023 May 4, 2023 | $127.28M | $122.18M | -4.01% | -$0.36 | -$0.50 | -38.89% | — | — |
| Q1 2023 Feb 23, 2023 | $127.28M | $128.43M | +0.90% | -$0.32 | -$0.36 | -12.50% | — | — |
| Q4 2022 Oct 27, 2022 | $130.61M | $131.00M | +0.30% | -$0.30 | -$0.25 | +16.67% | — | — |
| Q3 2022 Jul 28, 2022 | $134.97M | $140.87M | +4.37% | -$0.14 | -$0.23 | -64.29% | — | — |
| Q2 2022 Apr 28, 2022 | $134.08M | $137.55M | +2.59% | -$0.17 | -$0.04 | +76.47% | — | — |
| Q1 2022 Feb 24, 2022 | $133.00M | $133.21M | +0.16% | -$0.10 | -$0.25 | -150.00% | — | — |
| Q4 2021 Oct 28, 2021 | $106.29M | $133.61M | +25.70% | -$0.06 | -$0.13 | -116.67% | — | — |
| Q3 2021 Jul 29, 2021 | $141.89M | $133.52M | -5.90% | -$0.01 | -$0.14 | -1674.40% | — | — |
| Q2 2021 Apr 29, 2021 | $139.77M | $134.69M | -3.63% | -$0.01 | -$0.04 | -300.00% | — | — |